Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

A steroid metabolizing gene variant in a polyfactorial model improves risk prediction in a high incidence breast cancer population.

Jupe ER, Dalessandri KM, Mulvihill JJ, Miike R, Knowlton NS, Pugh TW, Zhao LP, DeFreese DC, Manjeshwar S, Gramling BA, Wiencke JK, Benz CC.

BBA Clin. 2014 Nov 8;2:94-102. doi: 10.1016/j.bbacli.2014.11.001. eCollection 2014 Dec.

2.

Vitamin D receptor polymorphisms and breast cancer risk in a high-incidence population: a pilot study.

Dalessandri KM, Miike R, Wiencke JK, Farren G, Pugh TW, Manjeshwar S, DeFreese DC, Jupe ER.

J Am Coll Surg. 2012 Nov;215(5):652-7. doi: 10.1016/j.jamcollsurg.2012.06.413. Epub 2012 Aug 4.

PMID:
22867716
3.

Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.

Diergaarde B, Potter JD, Jupe ER, Manjeshwar S, Shimasaki CD, Pugh TW, Defreese DC, Gramling BA, Evans I, White E.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1751-9. doi: 10.1158/1055-9965.EPI-08-0168.

4.

Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk.

Ralph DA, Zhao LP, Aston CE, Manjeshwar S, Pugh TW, DeFreese DC, Gramling BA, Shimasaki CD, Jupe ER.

Cancer. 2007 May 15;109(10):1940-8.

5.

Oligogenic combinations associated with breast cancer risk in women under 53 years of age.

Aston CE, Ralph DA, Lalo DP, Manjeshwar S, Gramling BA, DeFreese DC, West AD, Branam DE, Thompson LF, Craft MA, Mitchell DS, Shimasaki CD, Mulvihill JJ, Jupe ER.

Hum Genet. 2005 Feb;116(3):208-21. Epub 2004 Dec 21.

PMID:
15611867
6.

Identification of transferrin and inhibin-like proteins in matrigel.

Dirami G, Papadopoulos V, Kleinman HK, Defreese DC, Musto NA, Dym M.

In Vitro Cell Dev Biol Anim. 1995 Jun;31(6):404-11. No abstract available.

PMID:
8589878

Supplemental Content

Loading ...
Support Center